dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorFaculdade de Medicina de São José do Rio Preto (FAMERP)
dc.date.accessioned2014-05-27T11:23:37Z
dc.date.available2014-05-27T11:23:37Z
dc.date.created2014-05-27T11:23:37Z
dc.date.issued2008-07-30
dc.identifierGenetics and Molecular Research, v. 7, n. 2, p. 527-533, 2008.
dc.identifier1676-5680
dc.identifierhttp://hdl.handle.net/11449/70499
dc.identifier10.4238/vol7-2gmr448
dc.identifier2-s2.0-47949085991
dc.identifier2-s2.0-47949085991.pdf
dc.description.abstractAutism spectrum disorders are severe psychiatric diseases commonly identified in the population. They are diagnosed during childhood and the etiology has been much debated due to their variations and complexity. Onset is early and characterized as communication and social interaction disorders and as repetitive and stereotyped behavior. Austistic disorders may occur together with various genetic and chromosomal diseases. Several chromosomal regions and genes are implicated in the predisposition for these diseases, in particular those with products expressed in the central nervous system. There are reports of autistic and mentally handicapped patients with submicroscopic subtelomeric alterations at the distal end of the long arm of chromosome 2. Additionally, there is evidence that alterations at 2q37 cause brain malformations that result in the autistic phenotype. These alterations are very small and not identified by routine cytogenetics to which patients are normally submitted, which may result in an underestimation of the diagnosis. This study aimed at evaluating the 2q37 region in patients with autistic disorders. Twenty patients were studied utilizing the fluorescence in situ hybridization technique with a specific probe for 2q37. All of them were also studied by the GTC banding technique to identify possible chromosomal diseases. No alterations were observed in the 2q37 region of the individuals studied, and no patient presented chromosomal diseases. This result may be due to the small sample size analyzed. The introduction of routine analysis of the 2q37 region for patients with autistic disorders depends on further studies. ©FUNPEC-RP.
dc.languageeng
dc.relationGenetics and Molecular Research
dc.relation0,439
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectAutism spectrum disorders
dc.subjectChromosome 2
dc.subjectFISH technique
dc.subjectFluorescence in situ hybridization
dc.subjectautism
dc.subjectchromosome 2q
dc.subjectchromosome aberration
dc.subjectchromosome banding pattern
dc.subjectclinical article
dc.subjectfluorescence in situ hybridization
dc.subjecthuman
dc.subjecthuman tissue
dc.subjectAutistic Disorder
dc.subjectChild
dc.subjectChild Development Disorders, Pervasive
dc.subjectChromosome Aberrations
dc.subjectChromosomes, Human, Pair 2
dc.subjectCytogenetic Analysis
dc.subjectGenetic Predisposition to Disease
dc.subjectHumans
dc.subjectIn Situ Hybridization, Fluorescence
dc.subjectMetaphase
dc.subjectTelomere
dc.titleSubtelomeric region of chromosome 2 in patients with autism spectrum disorders
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución